- First Major Analysis of Human Protein Atlas
- A New Study Links XRCC2 Mutations to Cisplatin Resistance in Testicular Cancer
- Withdrawal of the Application for a Change to the Marketing Authorisation for Tegafur/Gimeracil/Oteracil
- Annals of Oncology Press Release: Lung Cancer Predicted to Overtake Breast Cancer as Leading Cause of Cancer Death Among European Women in...
- ESMO Press Release: ESMO Delivers on Dynamic Force Strategy to Improve Cancer Research in Europe
- European Medicines Agency Recommends a Variation to the Terms of the Marketing Authorisation for Protein Bound Paclitaxel
Providing practical opinion to support best practice for busy healthcare professionals